# Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy

> **NCT02296294** · NA · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 15 (actual)

## Conditions studied

- Fluid Shifts
- Body Fluid Compartments

## Interventions

- **DRUG:** Elo-mel® (Fresenius Kabi Austria)
- **DEVICE:** Body Composition Monitoring

## Key facts

- **NCT ID:** NCT02296294
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296294, "Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02296294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*